John Mesko, MD
Adult Reconstructive Orthopaedic Surgery · Lansing, MINPI 1043200306
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,631 of the $2,441 with a category attached, or 66.8%. 12 manufacturers reported payments, led by Conformis, Inc. at 37.0% of the total. Reporting peaked in 2019 at $1,669 and has fallen 88.5% since, to $191 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in MI, where the typical reported total is $8,679.
Across 32 payments — averaging $76.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Conformis, Inc.$904
- Stryker$558
- Smith+Nephew$285
- Zimmer Biomet$148
- Arthrex$140
- Biocomposites Inc$121
- plus $286 from 6 others
Across 21 payments — averaging $4786.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$101K
What the payments were for
- Travel & lodging$81033%
- Food & beverage$1,63167%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Conformis, Inc. | 12 | $904 |
| Stryker | 5 | $558 |
| Smith+Nephew | 4 | $285 |
| Zimmer Biomet | 2 | $148 |
| Arthrex | 1 | $140 |
| Biocomposites Inc | 1 | $121 |
| Onkos Surgical, Inc. | 1 | $117 |
| Boston Scientific | 1 | $63 |
| Orthofix Medical, Inc. | 2 | $44 |
| AbbVie | 1 | $23 |
| Dynasplint Systems Inc. | 1 | $22 |
| Tracpatch Health, Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iTotal CR$582
- MAKO$396
- TRIATHLON$146
- NAV - KNEE NAVIGATION SOFTWARE AND INSTRUMENTATION$146
- BIRMINGHAM HIP$136
- REAL INTELLIGENCE$136
- Tandem$136
- Stimulan$121
- ELEOS LIMB SALVAGE SYSTEM$117
- Persona Revision$107
How this compares
$2,441 in reported general payments places this provider in the 25th percentile of 35 adult reconstructive orthopaedic surgery providers in Michigan.
See all adult reconstructive orthopaedic surgery providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 78 | $756 |
| Celecoxib | 76 | $741 |
| Meloxicam | 223 | $568 |
| Ibuprofen | 12 | $113 |
| Amoxicillin | 30 | $71 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Lansing
- Charles TauntLansing$126K
- Daniel MeskoLansing$99K
- Jason CochranLansing$9K
- Michael MasiniYpsilanti$6.3M
- Jeffrey DeclaireRochester$5.4M
- Trevor BankaDetroit$339K
- Timothy EkpoGrand Blanc$295K
- Nicholas FrischAuburn Hills$244K
- Brian de BeaubienSaginaw$117K
- Anthony GemayelFlint$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.